Immunome Q3 EPS $(0.36) Up From $(0.75) YoY, Sales $3.56M
Portfolio Pulse from Benzinga Newsdesk
Immunome (NASDAQ:IMNM) reported Q3 losses of $(0.36) per share, a 52% increase from $(0.75) per share YoY. The company also reported $3.56 million in sales this quarter.
November 09, 2023 | 1:21 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Immunome's Q3 losses per share decreased by 52% YoY, and the company reported $3.56 million in sales.
Immunome's Q3 earnings report shows a significant decrease in losses per share compared to the same period last year, which is a positive sign for the company's financial health. This, along with the reported sales, could potentially lead to a positive impact on the company's stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100